Bluejay Therapeutics Announces First Patient Dosed in AZURE-1 Global Pivotal Clinical Trial Evaluating Brelovitug (BJT-778) as a Monotherapy Treatment for Chronic Hepatitis D
Related Posts
/Microsoft%20Corporation%20logo%20on%20sign-by%20Jean-Luc%20Ichard%20via%20iStock.jpg?ssl=1 "Dear Microsoft Stock Fans, Mark Your Calendars for January 28")
Dear Microsoft Stock Fans, Mark Your Calendars for January 28
By Yiannis Zourmpanos Publication Date: 2026-01-20 15:33:00 Microsoft Corporation logo on sign-by Jean-Luc Ichard via iStock With a market cap…
Microsoft’s new H200 v5 series VMs for Azure aim to supercharge GPU performance
Microsoft has announced the launch of new Azure virtual machines (VMs) aimed specifically at ramping up cloud-based AI supercomputing capabilities.…
Announcing new models, customization tools, and enterprise agent upgrades in Azure AI Foundry | Microsoft Azure Blog
We are excited to announce major updates to Azure AI Foundry, our integrated platform for designing, customizing, and managing enterprise-grade…